Physician

Jessica Moon, M.D.

According to 2025 Medicare claims, Jessica Moon, M.D. (NPI: 1952749681) practices ophthalmology in the Barnstable Town, MA market, with the plurality of this provider's patient population coming from Barnstable, MA. This provider's primary affiliated billing organization is OPHTHALMIC CONSULTANTS OF BOSTON, INC. (NPI: 1437374428; TIN: 04-2500346) and primary practice location at 02563-2302. Moon is affiliated with the Mass General Brigham ACO, LLC (ACO ID: A4641), participating under the MSSP model.

Moon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,439 traditional Medicare patients, billed 8,514 HCPCS/CPT codes, and received $638,973 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 12,003 prescription claims across 1,988 beneficiaries totaling $977,602 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 8 records totaling $255. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $5,203 to $638,973. Similarly, Part D prescription costs have moved sharply higher in recent years, from $21,915 to $977,602. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$319K$639K2017 Medicare payment: $5,203 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $89,848 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $283,976 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $354,897 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $511,996 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $459,355 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $545,250 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $638,973 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
20175382$5,203
20184871,282$89,848
20191,2374,705$283,976
20201,6344,938$354,897
20211,8386,657$511,996
20221,8306,022$459,355
20232,1297,309$545,250
20242,4398,514$638,973

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$489K$978K2015 Drug cost: $21,915 (USD; Tot_Drug_Cst)2016 Drug cost: $8,703 (USD; Tot_Drug_Cst)2017 Drug cost: $44,110 (USD; Tot_Drug_Cst)2018 Drug cost: $39,431 (USD; Tot_Drug_Cst)2019 Drug cost: $203,765 (USD; Tot_Drug_Cst)2020 Drug cost: $420,379 (USD; Tot_Drug_Cst)2021 Drug cost: $736,437 (USD; Tot_Drug_Cst)2022 Drug cost: $734,931 (USD; Tot_Drug_Cst)2023 Drug cost: $908,352 (USD; Tot_Drug_Cst)2024 Drug cost: $977,602 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201563180$21,915
201661123$8,703
2017122298$44,110
2018238584$39,431
20195342,297$203,765
20208214,370$420,379
20211,0616,792$736,437
20221,1426,646$734,931
20231,4468,293$908,352
20241,98812,003$977,602

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system1,9122,025$84
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more8871,124$63
92012Established patient problem focused exam of visual system483577$62
92083Exam of visual field with extended testing1,2011,258$45
92133Imaging of optic nerve1,4651,512$25

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost28215,672$149,448
RhopressaNetarsudil Mesylate30212,568$137,855
RestasisCyclosporine522,640$54,722
Bromfenac SodiumBromfenac Sodium25612,890$51,261
RocklatanNetarsudil Mesylat/Latanoprost883,718$48,169

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$255Glaukos Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jessica Moon, M.D.?

Tedicare shows public-source Medicare data for Jessica Moon, M.D. (NPI 1952749681), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jessica Moon, M.D. have ACO affiliation data?

Jessica Moon, M.D. is shown with ACO affiliation data for Mass General Brigham ACO, LLC (MSSP, ACO ID A4641).

What billing organization is linked to Jessica Moon, M.D.?

Jessica Moon, M.D. is linked to OPHTHALMIC CONSULTANTS OF BOSTON, INC. (billing NPI 1437374428) in the available physician profile data.

Does Jessica Moon, M.D. have Open Payments data?

Jessica Moon, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.